sb 216763 has been researched along with Hyperactivity, Motor in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Miller, JS; Tallarida, RJ; Unterwald, EM | 2 |
| Enman, NM; Unterwald, EM | 1 |
3 other study(ies) available for sb 216763 and Hyperactivity, Motor
| Article | Year |
|---|---|
Cocaine-induced hyperactivity and sensitization are dependent on GSK3.
Topics: Animals; Caudate Nucleus; Cocaine; Cocaine-Related Disorders; Enzyme Activation; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Hyperkinesis; Indoles; Locomotion; Male; Maleimides; Mice; Phosphorylation; Protein Kinase Inhibitors; Protein Processing, Post-Translational; Putamen; Stereotyped Behavior; Valproic Acid | 2009 |
Inhibition of GSK3 attenuates dopamine D1 receptor agonist-induced hyperactivity in mice.
Topics: Animals; Behavior, Animal; Benzazepines; Dopamine Agonists; Dose-Response Relationship, Drug; Glycogen Synthase Kinase 3; Hyperkinesis; Indoles; Male; Maleimides; Mice; Motor Activity; Receptors, Dopamine D1 | 2010 |
Inhibition of GSK3 attenuates amphetamine-induced hyperactivity and sensitization in the mouse.
Topics: Amphetamine; Animals; Brain; Central Nervous System Stimulants; Glycogen Synthase Kinase 3; Hyperkinesis; Indoles; Male; Maleimides; Mice; Motor Activity; Phosphorylation; Stereotyped Behavior | 2012 |